This means your blood has too many red blood cells. Red blood cells carry oxygen, so having too many can make your blood thicker and increase your risk of blood clots or stroke. It's usually caused by your body making too many red blood cells.
Every report comes from a Lived member, sent anonymously.
Have you had Phlebotomy for Polycythemia?
Polycythemia, also called erythrocytosis, means the blood holds a higher concentration of red blood cells than normal. It usually shows up on a routine blood count as a high hemoglobin (the oxygen-carrying protein inside red cells) or a high hematocrit (the share of blood volume made up of red cells). Many people feel well when it is first found. Polycythemia is a finding with several possible explanations rather than a single disease, and the explanation matters more than the number. In polycythemia vera, a chronic bone marrow disorder in the group doctors call myeloproliferative neoplasms, the marrow makes too many red cells on its own, often along with extra white cells and platelets. In secondary polycythemia, the marrow is responding normally to something else, most often low oxygen levels or a medicine such as testosterone. A result can also look high only because the fluid part of the blood is reduced, without any true excess of red cells. When red cells are truly increased, the blood becomes thicker. In polycythemia vera this raises the risk of blood clots, and some people notice headaches, dizziness, a reddened face, vision changes or itching after a warm bath or shower.
Secondary polycythemia is a response to another condition or exposure. Long-term low oxygen is a frequent driver: when tissues are short of oxygen, the kidneys release more erythropoietin (EPO), the hormone that tells the bone marrow to make red cells. Chronic lung disease such as COPD (chronic obstructive pulmonary disease), heart conditions present from birth that let oxygen-poor blood bypass the lungs, and living at high altitude can all do this. Tobacco use, testosterone and other androgens, injected erythropoietin, diuretics (water pills), a group of diabetes medicines called SGLT2 inhibitors (such as canagliflozin), a kidney transplant and, rarely, kidney or liver tumors are other recognized contributors. Polycythemia vera starts with a genetic change acquired during life in a single bone marrow stem cell, almost always in a gene called JAK2. It is not usually inherited, and why the change happens is unknown. It is more common in men and is typically diagnosed around age 60, though younger adults can be affected. Rarely, polycythemia runs in families because of an inherited gene variant; it then tends to be present from childhood or early adulthood. For many people whose count stays high without polycythemia vera, no specific cause is found despite thorough testing. This is called idiopathic erythrocytosis.
Normal ranges depend on sex and on altitude. Hematologists (blood specialists) generally look further when hemoglobin is above 16.5 grams per deciliter or hematocrit is above 49% in men, or above 16 grams per deciliter or 48% in women. These are also the levels used in the criteria for polycythemia vera. Because a single result can be misleading, the count is confirmed on at least two blood tests taken at different times. The first question is whether polycythemia vera is the cause. A blood test for a JAK2 gene change finds it in nearly everyone with the disease. A blood level of erythropoietin adds context: a low level points toward the marrow overproducing on its own, while a normal or high level fits a response to low oxygen or another trigger. A complete blood count showing high white cells or platelets, or an enlarged spleen on examination, also suggests polycythemia vera, and some people need a bone marrow biopsy to confirm it. If polycythemia vera is ruled out, the search turns to secondary causes. That usually means reviewing medicines and tobacco use, checking oxygen levels (sometimes overnight to look for sleep-related breathing problems), lung and heart tests, and an abdominal ultrasound of the kidneys and liver. A count that has been high since youth, especially with affected relatives, can lead to specialized testing for inherited causes.
Treatment depends on the cause, and the approach for polycythemia vera does not automatically carry over to other types. For polycythemia vera, the main goal is preventing blood clots, which cause most of the disease's serious harm. The foundation for everyone is phlebotomy, removing about a pint of blood at a time much like a blood donation, to bring the hematocrit below 45% and keep it there. Most people also take low-dose aspirin, which lowers clot risk but adds some risk of stomach bleeding. Managing blood pressure, cholesterol, diabetes and smoking matters as much as the blood count itself. People at higher risk of clots, generally those over 60 or anyone who has already had a clot, are usually offered a medicine that slows blood cell production. Hydroxyurea, a long-used oral medicine, and interferon, an injected treatment often preferred during pregnancy, are the usual first choices. Ropeginterferon alfa-2b (Besremi), injected under the skin every two weeks, is approved in the US for adults with polycythemia vera; interferons need monitoring because they can cause flu-like symptoms and, less commonly, mood changes and other serious problems. Ruxolitinib (Jakafi), a pill that blocks the overactive JAK2 signal, is approved for people whom hydroxyurea did not help or who could not tolerate it, and it can ease stubborn itching. Itching may also respond to antihistamines, other medicines or light therapy. For secondary polycythemia, treatment aims at the cause. Oxygen therapy for low oxygen levels, care for sleep apnea, and lowering or pausing a testosterone dose can each bring the count down, and stopping smoking is worthwhile for everyone. After a kidney transplant, an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (two families of blood pressure medicines) usually corrects it. Routine phlebotomy and aspirin are not automatic here: the evidence that the extra red cells cause clots is weaker than in polycythemia vera, and in some lung conditions a higher count partly compensates for low oxygen. Phlebotomy is reserved for selected people with very high levels or symptoms, and for people with heart conditions present from birth those decisions belong with their specialist heart team.
Secondary polycythemia often improves when its cause is treated. When the cause is lasting, such as chronic lung disease, the count may stay somewhat high and is watched alongside the underlying condition. Idiopathic erythrocytosis is usually followed with periodic blood counts and attention to heart and blood vessel risk factors, since its risk of clots and bleeding appears lower than in polycythemia vera. Polycythemia vera is a lifelong condition, but it usually progresses slowly, and many people live with it for decades. Average survival is about 15 years from diagnosis overall and more than 35 years for people diagnosed at 40 or younger. Daily life involves regular blood counts, phlebotomy sessions that are frequent at first and spaced out once the hematocrit is controlled, and medicine adjustments over time. Repeated phlebotomy deliberately lowers the body's iron, which can bring its own tiredness. Itching, fatigue and a full feeling under the left ribs from an enlarged spleen can affect comfort and sleep, and they are worth raising because they can often be treated. Over about 20 years, roughly a quarter of people with polycythemia vera have a clot, about 1 in 6 develop myelofibrosis (scarring of the bone marrow that disrupts blood cell production) and about 1 in 25 develop acute myeloid leukemia. This is why follow-up with a hematologist continues even when someone feels well.
Arrange a visit if a blood test shows a high hemoglobin or hematocrit, especially on more than one test, or if you have ongoing headaches, dizziness, a reddened face, or itching after warm baths or showers. If you have polycythemia vera, contact your care team promptly about a newly swollen, painful leg, which can signal a clot in a deep vein. Call 911 for signs of a stroke, such as a drooping face, weakness on one side or slurred speech, or for sudden chest pain, trouble breathing or coughing up blood, which can mean a clot has reached the lungs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Polycythemia is like, what's helped you, or ask the community a question.